Lung cancer is the leading cause of cancer death in the United States and worldwide. The SU2C–LUNGevity Foundation–ALA Lung Cancer Interception Dream Team proposes several complementary strategies to help prevent patients from developing lung cancer.
The team is working to create an atlas of precancer of the lung that can help identify the types of cancerous lung tissue that will require aggressive treatment. The team is also attempting to identify treatments that can prevent these abnormal lesions from progressing to invasive lung cancer.
In addition, the researchers are developing two sets of diagnostic tools that will be able to detect lung cancer early. The first set involves using nasal swabs and imaging to confirm whether lung abnormalities found in chest images are lung cancer or benign lung characteristics. The second set involves the use of blood tests to identify patients at the earliest stages of lung cancer recurrence.